Orthofix Medical Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Orthofix Medical Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Orthofix Medical Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.9M, a 32% increase year-over-year.
  • Orthofix Medical Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$97M, a 14.3% increase year-over-year.
  • Orthofix Medical Inc. annual Operating Income (Loss) for 2023 was -$139M, a 948% decline from 2022.
  • Orthofix Medical Inc. annual Operating Income (Loss) for 2022 was -$13.3M, a 59.6% decline from 2021.
  • Orthofix Medical Inc. annual Operating Income (Loss) for 2021 was -$8.32M, a 32.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$97M -$24.9M +$11.7M +32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$109M -$29.3M +$30.4M +50.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$139M -$18.3M -$7.27M -65.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$132M -$24.4M -$18.7M -322% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$113M -$36.6M -$43.3M -652% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$69.9M -$59.7M -$56.6M -1840% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$13.3M -$11M -$1.69M -18.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$11.6M -$5.79M -$5.47M -1749% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$6.1M $6.64M +$2.37M +55.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$8.48M -$3.08M -$162K -5.56% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$8.32M -$9.35M -$13.1M -352% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $4.74M -$313K -$4.49M -107% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $9.23M $4.27M +$25.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$16M -$2.92M -$9.77M -143% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$6.27M $3.71M -$390K -9.52% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$5.88M $4.18M +$23.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$28.9M -$21M -$21.5M -4756% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$7.48M $6.85M +$11.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$18.8M $4.1M -$8.31M -67% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-24
Q3 2019 -$10.5M -$18.9M -$22.8M -583% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $12.3M $451K -$5.46M -92.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $17.8M -$4.45M -$12.3M -157% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $30.1M $12.4M -$5.46M -30.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 $35.6M $3.91M -$5.13M -56.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 $40.7M $5.92M -$2.08M -26% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 $42.8M $7.87M +$1.95M +33% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 $40.8M $17.9M +$10.4M +141% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-25
Q3 2017 $30.4M $9.03M -$237K -2.56% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-25
Q2 2017 $30.6M $8M +$10.7M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-25
Q1 2017 $19.9M $5.92M -$1.16M -16.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-25
Q4 2016 $21.1M $7.42M +$36K +0.49% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 $21M $9.27M +$5.13M +124% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-26
Q2 2016 $15.9M -$2.7M -$7.62M -155% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-26
Q1 2016 $23.5M $7.08M +$14.3M Jan 1, 2016 Mar 31, 2016 10-K 2018-02-26
Q4 2015 $9.26M $7.38M +$3.43M +86.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $5.83M $4.14M -$2.37M -36.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-27
Q2 2015 $8.2M $4.93M -$1.78M -26.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-27
Q1 2015 $9.97M -$7.19M -$7.16M -24700% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-27
Q4 2014 $17.1M $3.95M +$14M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $3.1M $6.51M +$20.6M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$17.5M $6.7M -$216K -3.12% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$17.3M -$29K -$6.1M -100% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$11.2M -$10.1M -$36.6M -138% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-29
Q3 2013 $25.4M -$14.1M -$31M -183% Jul 1, 2013 Sep 30, 2013 10-K 2015-04-29
Q2 2013 $56.4M $6.92M -$9.7M -58.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-04-29
Q1 2013 $66.2M $6.07M -$8.72M -59% Jan 1, 2013 Mar 31, 2013 10-K 2015-04-29
Q4 2012 $74.9M $26.5M +$18.3M +224% Oct 1, 2012 Dec 31, 2012 10-K/A 2015-03-31
Q3 2012 $56.5M $16.9M -$4.02M -19.2% Jul 1, 2012 Sep 30, 2012 10-K/A 2015-03-31
Q2 2012 $60.6M $16.6M +$4.26M +34.5% Apr 1, 2012 Jun 30, 2012 10-K/A 2015-03-31
Q1 2012 $56.3M $14.8M +$50.4M Jan 1, 2012 Mar 31, 2012 10-K/A 2015-03-31
Q4 2011 $5.9M $8.17M Oct 1, 2011 Dec 31, 2011 10-K/A 2014-03-24
Q3 2011 $21M +$1.97M +10.4% Jul 1, 2011 Sep 30, 2011 10-K/A 2014-03-24
Q2 2011 $12.4M -$8.85M -41.7% Apr 1, 2011 Jun 30, 2011 10-K/A 2014-03-24
Q1 2011 -$35.6M Jan 1, 2011 Mar 31, 2011 10-K/A 2014-03-24
Q3 2010 $19M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $21.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.